Clinical Trial Update: Study of Anti-Mesothelin Car NK Cells in Epithelial Ovarian Cancer [EARLY_Phase 1]

View source ↗

Summary

An early-phase study evaluating anti-mesothelin CAR NK cells for epithelial ovarian cancer is underway; sponsorship is Allife Medical Science and Technology Co.…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Epithelial Ovarian Cancer

Drugs mentioned

• Anti-Mesothelin CAR NK cells

Snippet

Sponsor: Allife Medical Science and Technology Co., Ltd. | Conditions: Epithelial Ovarian Cancer | EARLY_Phase 1 | Status: UNKNOWN